| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

WHO publishes Emergency Use Listing procedure and roadmap to make new medical products more readily available during health emergencies

IVD

VCP

Announcement

3 February, 2020 - 11:00 (CET)

WHO published the Emergency Use Listing (EUL) procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.

New WHO Public Assessment Reports (WHOPARs) published

Announcement

30 January, 2020 - 02:00 (CET)

New WHO Public Assessment Reports (WHOPARs) published

Announcement

28 January, 2020 - 12:00 (CET)

Rwanda joins the collaborative registration procedure

Announcement

28 January, 2020 - 11:00 (CET)

7th Invitation to manufacturers of medicinal products for treatment of Neglected Tropical Diseases (NTDs), to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit

Announcement

24 January, 2020 - 02:00 (CET)

Products added under:

Singl

New WHO Public Inspection Reports (WHOPIRs) published

Announcement

23 January, 2020 - 02:00 (CET)

Launch of pilot programme for international cooperation in GMP inspections of manufacturers of sterile medicinal products for human use

Announcement

16 January, 2020 - 11:00 (CET)

International collaboration in the inspection of manufacturers of active pharmaceutical ingredients has been beneficial over the last few years (1).

New WHO Public Inspection Reports (WHOPIRs) published

Announcement

16 January, 2020 - 02:00 (CET)

Malaysia joins the collaborative registration procedure

Announcement

14 January, 2020 - 02:00 (CET)

Hetero’s dolutegravir/lamivudine/tenofovir tablet prequalified

19 December, 2019 - 22:00 (CET)

WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:

Subscribe to